机构:[1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院内科科室血液内科[2]Hematology Research Center of Yunnan Province, Kunming, China.[3]Department of Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院
第一作者机构:[1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China.[2]Hematology Research Center of Yunnan Province, Kunming, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Hematology, the First Affiliated Hospital of Kunming Medical University, Kunming, China.[2]Hematology Research Center of Yunnan Province, Kunming, China.
推荐引用方式(GB/T 7714):
Li Zixuan,Yang Yuanyuan,Wu Kun,et al.Myeloid leukemia factor 1: A "double-edged sword" in health and disease[J].FRONTIERS IN ONCOLOGY.2023,13:1124978.doi:10.3389/fonc.2023.1124978.
APA:
Li Zixuan,Yang Yuanyuan,Wu Kun,Li Yuntao&Shi Mingxia.(2023).Myeloid leukemia factor 1: A "double-edged sword" in health and disease.FRONTIERS IN ONCOLOGY,13,
MLA:
Li Zixuan,et al."Myeloid leukemia factor 1: A "double-edged sword" in health and disease".FRONTIERS IN ONCOLOGY 13.(2023):1124978